The North America In Vitro Fertilization (IVF) Market is witnessing substantial growth, driven by rising infertility rates, technological advancements, and evolving social trends. The market size was valued at USD 3,100 Million in 2025 and is projected to reach USD 7,850 Million by 2035, expanding at a CAGR of 8.9% from 2024 to 2035.
The economic impact of tariffs on "North America In Vitro Fertilization Market".
Market Growth Drivers
Increasing Prevalence of Infertility Disorders: The prevalence of infertility due to lifestyle changes, delayed parenthood, and rising age at marriage is increasing across North America. According to the Centers for Disease Control and Prevention (CDC), approximately 12% of women aged 15-44 years in the US experience difficulty in getting pregnant or carrying a pregnancy to term. This has created a robust demand for IVF services and solutions. Companies like CooperSurgical are expanding their advanced IVF portfolio to cater to this growing patient pool, launching innovative technologies that improve the outcomes of fertility treatments.
Advancements in IVF Technologies: Rapid advancements in IVF-related technologies, such as Preimplantation Genetic Testing (PGT), embryo culture media, and time-lapse imaging, are significantly improving success rates, reducing complications, and enhancing the patient experience. In October 2023, Ferring Pharmaceuticals announced the launch of a new culture medium that increases the success rates of embryo implantation. These innovations are attracting more couples to opt for IVF procedures, further stimulating market growth.
Market Trends
Rising Adoption of Elective Egg Freezing: A growing number of women in North America are choosing to delay childbirth for career or personal reasons, fueling the demand for elective egg freezing. Leading fertility clinics such as CCRM (Colorado Center for Reproductive Medicine) have reported a spike in women opting for social egg freezing, especially in urban regions. This trend not only broadens the demographic seeking IVF but also prompts fertility centers to expand egg banking and preservation services.
Expansion of Telemedicine in Fertility Care: The post-pandemic environment has accelerated the integration of telemedicine into fertility treatment. Clinics like Extend Fertility and Kindbody are leveraging virtual consultations, remote monitoring, and digital patient engagement platforms to streamline IVF workflows. This trend is making IVF services more accessible, reducing travel and wait times, and improving patient satisfaction—ultimately driving higher market penetration.
Market Opportunities
Emergence of Genetic Testing and Personalized IVF: There is a significant opportunity for players providing comprehensive genetic screening and personalized treatment approaches. Companies such as CooperSurgical and Invitae are partnering with fertility clinics to integrate advanced genetic testing, enhancing embryo selection and treatment outcomes.
Untapped Markets in Canada and Mexico: While the U.S. dominates IVF procedures, increased awareness, government initiatives, and rising fertility tourism in Canada and Mexico present lucrative opportunities for market expansion. Local clinics and global fertility service providers are investing in these regions to capture growing demand.
North America IVF Market Revenue (USD Million), 2020-2035
The chart shows a steadily increasing trend in the North America IVF Market's revenue over the years 2020 to 2035. Starting at USD 1,650 Million in 2020, the market sees consistent growth attributed to increasing IVF procedures, technological innovations, and evolving patient demographics. Significant acceleration is observed post-2025, reflecting the impact of advancing technologies and increased market penetration particularly in urban centers. By 2035, revenues are projected to reach USD 7,850 Million, emphasizing strong long-term market potential.
North America IVF Market by Region Share (%) in 2025
The pie chart highlights the regional distribution of the North America IVF Market in 2025. The United States commands a dominant share of 74%, driven by the presence of advanced fertility clinics, supportive insurance policies, and technological leadership. Canada follows with 13% market share, owing to growing government support and cross-border IVF tourism. Mexico holds 8%, marking its emergence as a medical tourism hotspot. Rest of North America and the Caribbean collectively account for the remaining 5%, indicating room for expansion. The significant disparity underscores the U.S.'s centrality, but also hints at untapped growth in adjacent markets.
Recent Developments in North America IVF Market
In April 2024, CooperSurgical announced the acquisition of a next-generation artificial intelligence platform for embryo selection, integrating the latest advancements in AI into its IVF solutions. This move is aimed at improving embryo viability assessment and increasing success rates, reinforcing CooperSurgical’s position as a leader in fertility technology.
In March 2024, Kindbody launched its first fully-digital, end-to-end fertility platform in North America, including remote ovarian reserve testing and personalized fertility consultation. The platform leverages telemedicine and automated logistics, enhancing accessibility and patient engagement across remote and urban populations.
In February 2024, CCRM Fertility reported successful results from its pilot program using non-invasive PGT-A (Preimplantation Genetic Testing for Aneuploidies) methods. This development signals a potential shift toward less invasive embryo testing with fewer risks for patients, likely to be rapidly adopted across its network of clinics in North America.
Press Releases